Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
44.43
+0.08 (0.18%)
At close: Nov 19, 2025, 4:00 PM EST
45.29
+0.86 (1.94%)
Pre-market: Nov 20, 2025, 8:50 AM EST
Qiagen Revenue
Qiagen had revenue of $532.58M in the quarter ending September 30, 2025, with 6.12% growth. This brings the company's revenue in the last twelve months to $2.07B, up 5.32% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.07B
Revenue Growth
+5.32%
P/S Ratio
4.66
Revenue / Employee
$347,039
Employees
5,967
Market Cap
9.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
QGEN News
- 20 hours ago - Qiagen N.V. (QGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 days ago - Qiagen N.V. (QGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025 - Business Wire
- 13 days ago - Seattle's Parse Biosciences to be acquired by Qiagen for $225M - GeekWire
- 14 days ago - Qiagen N.V. (QGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase - Business Wire
- 15 days ago - QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions - Business Wire
- 22 days ago - QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing - Business Wire